Cite
HARVARD Citation
Chen, C. et al. (2022). A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C. JGH open. 6 (11), pp. 782-791. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chen, C. et al. (2022). A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C. JGH open. 6 (11), pp. 782-791. [Online].